Microbial ecology of the cystic fibrosis lung

References

1. Alvarez S., Herrero C., Bru E., Perdigon G. 2001; Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J Food Prot 64:1768–1774
   [Google Scholar]
2. Alvarez A. E., Ribeiro A. F., Hessel G., Bertuzzo C. S., Ribeiro J. D. 2004; Cystic fibrosis at a Brazilian center of excellence: clinical and laboratory characteristics of 104 patients and their association with genotype and disease severity. J Pediatr (Rio J) 80:371–379 [CrossRef]
   [Google Scholar]
3. Anzaudo M. M., Busquets N. P., Ronchi S., Mayoral C. 2005; Microorganismos patógenos aislados en muestras respiratorias de niños con fibrosis quística. Rev Argent Microbiol 37:129–134
   [Google Scholar]
4. Armstrong D. S., Grimwood K., Carlin J. B., Carzino R., Olinsky A., Phelan P. D. 1996; Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 21:267–275 [CrossRef]
   [Google Scholar]
5. Besier S., Smaczny C., Krahl A., Ackermann H., Brade V., Wichelhaus T. A., von Mallinckrodt C. 2007; Prevalence and clinical significance of Staphylococcus aureus small colony variants in cystic fibrosis lung disease. J Clin Microbiol 45:168–172 [CrossRef]
   [Google Scholar]
6. Burns J. L., Emerson J., Stapp J. R., Yim D. L., Krzewinski J., Louden L., Ramsey B. W., Clausen C. R. 1998; Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27:158–163 [CrossRef]
   [Google Scholar]
7. Chang W., Small D. A., Toghrol F., Bentley W. E. 2005; Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide. BMC Genomics 6:115 [CrossRef]
   [Google Scholar]
8. Ciofu O., Riis B., Pressler T., Poulsen H. E., Hoiby N. 2005; Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49:2276–2282 [CrossRef]
   [Google Scholar]
9. Coenye T., Goris J., Spilker T., Vandamme P., LiPuma J. J. 2002; Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol 40:2062–2069 [CrossRef]
   [Google Scholar]
10. Cystic Fibrosis Foundation 2004 Patient Registry 2004 Annual Report Bethesda, MD: Cystic Fibrosis Foundation;
    [Google Scholar]
11. De Vos D., De Chial M., Cochez C., Jansen S., Tummler B., Meyer J. M., Cornelis P. 2001; Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol 175:384–388 [CrossRef]
    [Google Scholar]
12. Döring G., Hoiby N. 2004; Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fib 3:67–91
    [Google Scholar]
13. Duan K., Dammel C., Stein J., Rabin H., Surette M. G. 2003; Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50:1477–1491 [CrossRef]
    [Google Scholar]
14. Eberl L. 2006; Quorum sensing in the genus Burkholderia . Int J Med Microbiol 296:103–110
    [Google Scholar]
15. Govan J. R. 1986; In vivo significance of bacteriocins and bacteriocin receptors. Scand J Infect Dis 49:Suppl31–37
    [Google Scholar]
16. Griffin A. S., West S. A., Buckling A. 2004; Cooperation and competition in pathogenic bacteria. Nature 430:1024–1027 [CrossRef]
    [Google Scholar]
17. Gutierrez J. P., Grimwood K., Armstrong D. S., Carlin J. B., Carzino R., Olinsky A., Robertson C. F., Phelan P. D. 2001; Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur Respir J 17:281–286 [CrossRef]
    [Google Scholar]
18. Haas B., Kraut J., Marks J., Zanker S. C., Castignetti D. 1991; Siderophore presence in sputa of cystic fibrosis patients. Infect Immun 59:3997–4000
    [Google Scholar]
19. Haase G., Skopnik H., Groten T., Kusenbach G., Posselt H.-G. 1991; Long-term fungal cultures from sputum of patients with cystic fibrosis. Mycoses 34:373–376
    [Google Scholar]
20. Harrison F., Buckling A. 2005; Hypermutability impedes cooperation in pathogenic bacteria. Curr Biol 15:1968–1971 [CrossRef]
    [Google Scholar]
21. Harrison F., Browning L. E., Vos M., Buckling A. 2006; Cooperation and virulence in acute Pseudomonas aeruginosa infections. BMC Biol 4:21 [CrossRef]
    [Google Scholar]
22. Haussler S., Ziegler I., Lottel A., Rohde M., Wehmhohner D., Saravanamuthu S., Tummler B., Steinmetz I., von Gotz F. 2003; Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol 52:295–301 [CrossRef]
    [Google Scholar]
23. Hoiby N. 1974; Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B Microbiol Immunol 82:541–550
    [Google Scholar]
24. Hoiby N., Rosendal K. 1980; Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. Acta Pathol Microbiol Scand B Microbiol Immunol 88:125–131
    [Google Scholar]
25. Hoiby N., Frederiksen B., Pressler T. 2005; Eradication of early Pseudomonas aeruginosa infection. J Cyst Fib 4 :Suppl. 249–54
    [Google Scholar]
26. Hooi D. S., Bycroft B. W., Chhabra S. R., Williams P., Pritchard D. I. 2004; Differential immune modulatory activity of Pseudomonas aeruginosa quorum-sensing signal molecules. Infect Immun 72:6463–6470 [CrossRef]
    [Google Scholar]
27. Kadouri D., O'Toole G. A. 2005; Susceptibility of biofilms to Bdellovibrio bacteriovorus attack. Appl Environ Microbiol 71:4044–4051 [CrossRef]
    [Google Scholar]
28. Kresse A. U., Dinesh S. D., Larbig K., Romling U. 2003; Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol Microbiol 47:145–158
    [Google Scholar]
29. Lambiase A., Raia V., Pezzo M., Sepe A., Carnovale V., Rossano F. 2006; Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis 6:4 [CrossRef]
    [Google Scholar]
30. Lebecque P., Leal T., Zylberberg K., Reychler G., Bossuyt X., Godding V. 2006; Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fib 5:237–244 [CrossRef]
    [Google Scholar]
31. Le Berre R., Faure K., Nguyen S., Pierre M., Ader F., Guery B. 2006; Quorum sensing: une nouvelle cible thérapeutique pour Pseudomonas aeruginosa . Med Mal Infect 36:349–357 [CrossRef]
    [Google Scholar]
32. LiPuma J. J., Dasen S. E., Nielson D. W., Stern R. C., Stull T. L. 1990; Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094–1096 [CrossRef]
    [Google Scholar]
33. Lording A., McGaw J., Dalton A., Beal G., Everard M., Taylor C. J. 2006; Pulmonary infection in mild variant cystic fibrosis: implications for care. J Cyst Fib 5:101–104 [CrossRef]
    [Google Scholar]
34. Lyczak J. B., Cannon C. L., Pier G. B. 2002; Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194–222 [CrossRef]
    [Google Scholar]
35. Mahenthiralingam E., Campbell M. E., Speert D. P. 1994; Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62:596–605
    [Google Scholar]
36. Mashburn L. M., Jett A. M., Akins D. R., Whiteley M. 2005; Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J Bacteriol 187:554–566 [CrossRef]
    [Google Scholar]
37. Massey R. C., Buckling A., ffrench-Constant R. 2004; Interference competition and parasite virulence. Proc Biol Sci 271:785–788 [CrossRef]
    [Google Scholar]
38. Michel-Briand Y., Baysse C. 2002; The pyocins of Pseudomonas aeruginosa . Biochimie 84:499–510 [CrossRef]
    [Google Scholar]
39. Moore J. E., Shaw A., Millar B. C., Downey D. G., Murphy P. G., Elborn J. S. 2005; Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading?. Br J Biomed Sci 62:175–178
    [Google Scholar]
40. Nixon G. M., Armstrong D. S., Carzino R., Carlin J. B., Olinsky A., Robertson C. F., Grimwood K. 2001; Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 138:699–704 [CrossRef]
    [Google Scholar]
41. Ojeniyi B., Birch-Andersen A., Mansa B., Rosdahl V. T., Hoiby N. 1991; Morphology of Pseudomonas aeruginosa phages from the sputum of cystic fibrosis patients and from the phage typing set. An electron microscopy study. Acta Pathol Microbiol Immunol Scand 99:925–930 [CrossRef]
    [Google Scholar]
42. Palmer K. L., Mashburn L. M., Singh P. K., Whiteley M. 2005; Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187:5267–5277 [CrossRef]
    [Google Scholar]
43. Petersen N. T., Hoiby N., Mordhorst C. H., Lind K., Flensborg E. W., Bruun B. 1981; Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma – possible synergism with Pseudomonas aeruginosa . Acta Paediatr Scand 70:623–628 [CrossRef]
    [Google Scholar]
44. Riedel K., Hentzer M., Geisenberger O., Huber B., Steidle A., Wu H., Høiby N., Givskov M., Molin S., Eberl L. 2001; N -Acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147:3249–3262
    [Google Scholar]
45. Rogers G. B., Carroll M. P., Serisier D. J., Hockey P. M., Jones G., Bruce K. D. 2004; Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42:5176–5183 [CrossRef]
    [Google Scholar]
46. Saiman L. 2004; Microbiology of early CF lung disease. Paediatr Respir Rev 5 (Suppl. A:S367–S369 [CrossRef]
    [Google Scholar]
47. Salunkhe P., Smart C. H., Morgan J. A., Panagea S., Walshaw M. J., Hart C. A., Geffers R., Tummler B., Winstanley C. 2005; A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 187:4908–4920 [CrossRef]
    [Google Scholar]
48. Santana M. A., Matos E., Franco R., Barreto D., Lemos A. C., do Socorro Fontoura M. 2003; Prevalence of pathogens in cystic fibrosis patients in Bahia. Brazil. Braz J Infect Dis 7:69–72
    [Google Scholar]
49. Smith D. L., Smith E. G., Pitt T. L., Stableforth D. E. 1998; Regional microbiology of the cystic fibrosis lung: a post-mortem study in adults. J Infect 37:41–43 [CrossRef]
    [Google Scholar]
50. Smith E. E., Buckley D. G., Wu Z., Saenphimmachak C., Hoffman L. R., D'Argenio D. A., Miller S. I., Ramsey B. W., Speert D. P. other authors 2006; Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103:8305–8306 [CrossRef]
    [Google Scholar]
51. Stites S. W., Plautz M. W., Bailey K., O'Brien-Ladner A. R., Wesselius L. J. 1999; Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am J Respir Crit Care Med 160:796–801 [CrossRef]
    [Google Scholar]
52. Toro H., Price S. B., McKee A. S., Hoerr F. J., Krehling J., Perdue M., Bauermeister L. 2005; Use of bacteriophages in combination with competitive exclusion to reduce Salmonella from infected chickens. Avian Dis 49:118–124 [CrossRef]
    [Google Scholar]
53. van Ewijk B. E., van der Zalm M. M., Wolfs T. F. W., van der Ent C. K. 2005; Viral respiratory infections in cystic fibrosis. J Cyst Fib 4:31–36 [CrossRef]
    [Google Scholar]
54. Villena J., Racedo S., Aguero G., Bru E., Medina M., Alvarez S. 2005; Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 135:1462–1469
    [Google Scholar]
55. Wahab A. A., Janahi I. A., Marafia M. M., El-Shafie S. 2004; Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation. J Trop Pediatr 50:229–233 [CrossRef]
    [Google Scholar]
56. West S. A., Griffin A. S., Gardner A., Diggle S. P. 2006; Social evolution theory for microorganisms. Nat Rev Microbiol 4:597–607 [CrossRef]
    [Google Scholar]
57. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K. C., Birrer P., Bellon G., Berger J. other authors 2002; Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109:317–325 [CrossRef]
    [Google Scholar]